A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
NCT01637246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4385
Last updated 2012-09-21
Summary
This is a retrospective chart review and will assess changes in IOP after treatment with any fixed combination in patients who previously received monotherapy.
Conditions
- Glaucoma, Open-Angle
- Ocular Hypertension
Interventions
- DRUG
-
Any Fixed Combination Therapy
Patients with POAG or OHT previously treated with monotherapy and currently treated with any fixed combination therapy. This was a retrospective chart review study, so no treatment was administered in this study.
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Medical Director · Allergan
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2011-11-30
- Completion
- 2011-11-30
Countries
- Spain
Study Locations
More Related Trials
-
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
NCT00069719 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
NCT00069706 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
NCT01241240 ·Status: COMPLETED ·Phase: PHASE3
-
ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects
NCT01668524 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
NCT01735214 ·Status: COMPLETED
-
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
NCT02061683 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT02636946 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00372931 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)
NCT01594970 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study
NCT03216902 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
NCT01868126 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00311389 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT02348476 ·Status: COMPLETED
-
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure
NCT00230763 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00293761 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
NCT05495061 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Preference Study
NCT00576342 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
NCT06666855 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
NCT02003534 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT00051142 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
NCT00716742 ·Status: COMPLETED
-
A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
NCT02020512 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00761709 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00287521 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
NCT01215786 ·Status: COMPLETED ·Phase: PHASE1